comparemela.com
  1. Home
  2. Live Updates
  3. F. Hoffmann-La Roche Ltd: Roche reports positive Phase I results for its dual GLP-1/GIP receptor agonist CT-388 in people with obesity : comparemela.com

F. Hoffmann-La Roche Ltd: Roche reports positive Phase I results for its dual GLP-1/GIP receptor agonist CT-388 in people with obesity

F. Hoffmann-La Roche Ltd: Roche reports positive Phase I results for its dual GLP-1/GIP receptor agonist CT-388 in people with obesity
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

Switzerland ,Japan ,United States ,America ,Yvette Petillon ,Simon Goldsborough ,Levi Garraway ,Kirti Pandey ,Sabine Borngr ,Rebekka Schnell ,Loren Kalm ,Birgit Masjost ,Nathalie Altermatt ,Sileia Urech ,Bruno Eschli ,Karsten Kleine ,Roche Group ,Genentech ,Head Of Global Product Development ,Chief Medical Officer ,Global Product ,Dow Jones Sustainability Indices ,Chugai Pharmaceutical ,Ihr Portfolio ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.